Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to extend the curative capability of stem cell transplant, gene therapy, genome editing and cell therapy to more patients. The first conditioning program in the company's portfolio is C100, under which it is developing antibody-drug conjugates (ADC) that specifically deplete host HSCs and immune cells. The company's key conditioning program, C200, is designed to specifically deplete HSCs and disease-causing cells. The company's lead ADC product candidate targets CD117, also known as c-Kit, which is highly expressed on HSCs and leukemia cells, making it an ideal target for conditioning across sets of diseases.
  • TickerMGTA
  • ISINUS55910K1088
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ValuEngine Rating and Forecast Report for MGTA

ResearchPool Subscriptions

Get the most out of your insights

Get in touch